Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription 26.08.2019 2 BMJ 1 Clin Infect Dis 1 Indian Pediatr 2 Infect Immun 1 J Immunol 1 J Infect Dis 1 J Pediatr 2 J Virol 2 Lancet 2 Lancet Child Adolesc Health 2 Lancet Infect Dis 3 Lancet Respir Med 3 MMWR Morb Mortal Wkly Rep 1 PLoS Comput Biol 3 PLoS One 10 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMJ

1. WISE J
   MMR vaccine: Johnson urges new impetus to increase uptake as UK loses measles-free status.
   BMJ. 2019;366:l5219.
   PubMed     Text format    
   
   
2. GUERY B, Galperine T, Barbut F
   Clostridioides difficile: diagnosis and treatments.
   BMJ. 2019;366:l4609.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

3. WANLAPAKORN N, Maertens K, Vongpunsawad S, Peunpa J, et al
   Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial.
   Clin Infect Dis. 2019 Aug 16. pii: 5550660. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Indian Pediatr

4. SANKLECHA M
   Measles-Rubella Campaign: Could Things Have Been Done Differently?
   Indian Pediatr. 2019;56:335.
   PubMed     Text format    
   
   

   
   Infect Immun

5. LEDBETTER L, Cherla R, Chambers C, Zhang Y, et al
   Eosinophils affect antibody isotype switching and may partially contribute to early vaccine-induced immunity against Coxiella burnetii.
   Infect Immun. 2019 Aug 19. pii: IAI.00376-19. doi: 10.1128/IAI.00376.
   PubMed     Text format     Abstract available
   
   
6. MACIEL M JR, Bauer D, Baudier RL, Bitoun J, et al
   Intradermal or sublingual delivery and heat-labile enterotoxin (LT) proteins shape immunologic outcomes to CFA/I fimbriae-derived subunit antigen vaccine against enterotoxigenic E. coli.
   Infect Immun. 2019 Aug 19. pii: IAI.00460-19. doi: 10.1128/IAI.00460.
   PubMed     Text format     Abstract available
   
   

   
   J Immunol

7. WAGSTAFFE HR, Pickering H, Houghton J, Mooney JP, et al
   Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function.
   J Immunol. 2019 Aug 19. pii: jimmunol.1801648. doi: 10.4049/jimmunol.1801648.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

8. SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
   Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
   J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Pediatr

9. KREPPEL A
   New, less-expensive inactivated polio vaccine non-inferior to conventional inactivated vaccine.
   J Pediatr. 2019;212:241-242.
   PubMed     Text format    
   
   

   
   J Virol

10. LI SS, Gilbert PB, Carpp LN, Pyo CW, et al
    Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial.
    J Virol. 2019 Aug 21. pii: JVI.02041-18. doi: 10.1128/JVI.02041.
    PubMed     Text format     Abstract available
    
    
11. HENRY C, Palm AE, Utset HA, Huang M, et al
    Monoclonal antibody responses after recombinant HA vaccine versus subunit inactivated influenza virus vaccine: a comparative study.
    J Virol. 2019 Aug 21. pii: JVI.01150-19. doi: 10.1128/JVI.01150.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

12. LOH LC
    Mandatory reporting and vaccination in North America.
    Lancet. 2019 Aug 13. pii: S0140-6736(19)31253.
    PubMed     Text format    
    
    
13. ZAROCOSTAS J
    Ebola outbreak declared a PHEIC, world waits for next steps.
    Lancet. 2019;394:287-288.
    PubMed     Text format    
    
    

    
    Lancet Child Adolesc Health

14. FATHIMA P, Gidding HF, McIntyre PB, Snelling TL, et al
    Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Lancet Child Adolesc Health. 2019 Aug 19. pii: S2352-4642(19)30249.
    PubMed     Text format     Abstract available
    
    
15. EADES S
    Pneumococcal vaccination in Australian children: divergent outcomes.
    Lancet Child Adolesc Health. 2019 Aug 19. pii: S2352-4642(19)30264.
    PubMed     Text format    
    
    

    
    Lancet Infect Dis

16. POSTON TB, Darville T
    First genital chlamydia vaccine enters in-human clinical trial.
    Lancet Infect Dis. 2019 Aug 12. pii: S1473-3099(19)30290.
    PubMed     Text format    
    
    
17. ABRAHAM S, Juel HB, Bang P, Cheeseman HM, et al
    Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.
    Lancet Infect Dis. 2019 Aug 12. pii: S1473-3099(19)30279.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Respir Med

18. MCSHANE H
    Insights and challenges in tuberculosis vaccine development.
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30274.
    PubMed     Text format     Abstract available
    
    
19. TAMERIS M, Mearns H, Penn-Nicholson A, Gregg Y, et al
    Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30251.
    PubMed     Text format     Abstract available
    
    
20. ACHKAR JM
    Prospects and challenges of a new live tuberculosis vaccine.
    Lancet Respir Med. 2019 Aug 12. pii: S2213-2600(19)30277.
    PubMed     Text format    
    
    

    
    MMWR Morb Mortal Wkly Rep

21. SENKOMAGO V, Henley SJ, Thomas CC, Mix JM, et al
    Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
    MMWR Morb Mortal Wkly Rep. 2019;68:724-728.
    PubMed     Text format     Abstract available
    
    
22. WALKER TY, Elam-Evans LD, Yankey D, Markowitz LE, et al
    National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018.
    MMWR Morb Mortal Wkly Rep. 2019;68:718-723.
    PubMed     Text format     Abstract available
    
    
23. MARTINEZ M, Shukla H, Nikulin J, Mbaeyi C, et al
    Progress Toward Poliomyelitis Eradication - Afghanistan, January 2018-May 2019.
    MMWR Morb Mortal Wkly Rep. 2019;68:729-733.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Comput Biol

24. HAY JA, Laurie K, White M, Riley S, et al
    Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets.
    PLoS Comput Biol. 2019;15:e1007294.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

25. DRURY RE, Pollard AJ, O'Connor D
    The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies.
    PLoS One. 2019;14:e0221143.
    PubMed     Text format     Abstract available
    
    
26. FRALEIGH NL, Oliva R, Lewicky JD, Martel AL, et al
    Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
    PLoS One. 2019;14:e0221708.
    PubMed     Text format     Abstract available
    
    
27. MAREFIAW TA, Yenesew MA, Mihirete KM
    Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.
    PLoS One. 2019;14:e0218470.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

28. ZHANG W, Wang Q
    The failure of news coverage supportive of human papillomavirus vaccination: The investigation of the effects of online comments on female college students' vaccination intention.
    Vaccine. 2019 Aug 14. pii: S0264-410X(19)31046.
    PubMed     Text format     Abstract available
    
    
29. HYER RN, Janssen RS
    Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70years.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31044.
    PubMed     Text format     Abstract available
    
    
30. CHANG LJ, Meng Y, Janosczyk H, Landolfi V, et al
    Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults >/=65years of age: A phase 3 randomized clinical trial.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31066.
    PubMed     Text format     Abstract available
    
    
31. HILKE J, Strobel H, Woelke S, Stoeter M, et al
    A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31050.
    PubMed     Text format     Abstract available
    
    
32. BOWEN W, Batra L, Pulsifer AR, Yolcu ES, et al
    Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.
    Vaccine. 2019 Aug 12. pii: S0264-410X(19)31024.
    PubMed     Text format     Abstract available
    
    
33. PATEL N, Massare MJ, Tian JH, Guebre-Xabier M, et al
    Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
    Vaccine. 2019 Aug 12. pii: S0264-410X(19)31010.
    PubMed     Text format     Abstract available
    
    
34. LAUPEZE B, Herve C, Di Pasquale A, Tavares Da Silva F, et al
    Adjuvant Systems for vaccines: 13years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood.
    Vaccine. 2019 Aug 13. pii: S0264-410X(19)31019.
    PubMed     Text format     Abstract available
    
    
35. VAN WIJHE M, de Boer PT, de Jong HJ, van Vliet H, et al
    Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis.
    Vaccine. 2019 Aug 13. pii: S0264-410X(19)31018.
    PubMed     Text format     Abstract available
    
    
36. CATALDI JR, Sevick C, Pyrzanowski J, Wagner N, et al
    Addressing personal parental values in decisions about childhood vaccination: Measure development.
    Vaccine. 2019 Aug 14. pii: S0264-410X(19)31048.
    PubMed     Text format     Abstract available
    
    
37. COSTANTINO C, Restivo V, Amodio E, Colomba GME, et al
    A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy).
    Vaccine. 2019 Aug 16. pii: S0264-410X(19)31064.
    PubMed     Text format     Abstract available
    
    

    
    Virus Res

38. SONG Y, Wei Q, Liu Y, Bai Y, et al
    Development of Novel Subunit Vaccine based on truncated fiber protein of Egg Drop Syndrome Virus and its immunogenicity in chickens.
    Virus Res. 2019 Aug 20:197728. doi: 10.1016/j.virusres.2019.197728.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: